Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,560 | 80 | 99.2% |
| Education | $12.01 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $234.26 | 12 | $0 (2024) |
| Axsome Therapeutics, Inc. | $213.25 | 13 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $110.99 | 7 | $0 (2024) |
| Biogen, Inc. | $107.19 | 4 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $77.73 | 4 | $0 (2024) |
| Amneal Pharmaceuticals LLC | $68.20 | 3 | $0 (2023) |
| Inspire Medical Systems, Inc. | $67.71 | 2 | $0 (2024) |
| Neurelis, Inc. | $64.17 | 3 | $0 (2024) |
| Eisai Inc. | $59.90 | 3 | $0 (2023) |
| Lundbeck LLC | $35.90 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $388.88 | 18 | Biogen, Inc. ($80.80) |
| 2023 | $886.08 | 45 | Axsome Therapeutics, Inc. ($166.91) |
| 2022 | $158.36 | 9 | Novartis Pharmaceuticals Corporation ($45.70) |
| 2021 | $138.90 | 9 | AbbVie Inc. ($96.45) |
All Payment Transactions
81 individual payment records from CMS Open Payments — Page 2 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Neurology | ||||||
| 10/18/2023 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: EPILEPSY | ||||||
| 10/17/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2023 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $16.03 | General |
| 10/05/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: PSYCHIATRY | ||||||
| 10/02/2023 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Immunology | ||||||
| 10/02/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Neurology | ||||||
| 09/19/2023 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $20.61 | General |
| Category: Neurology | ||||||
| 09/07/2023 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: NEUROLOGY | ||||||
| 09/07/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $5.79 | General |
| Category: Neurology | ||||||
| 09/05/2023 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Neuroscience | ||||||
| 08/22/2023 | ARGENX US, INC. | — | Food and Beverage | In-kind items and services | $23.94 | General |
| 08/16/2023 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: EPILEPSY | ||||||
| 08/11/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug), Ongentys | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Neuropsychiatry | ||||||
| 07/19/2023 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: Adenosine A2A Receptors | ||||||
| 06/29/2023 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $16.76 | General |
| Category: NEUROLOGY | ||||||
| 06/13/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $33.49 | General |
| Category: Neurology | ||||||
| 06/01/2023 | Sumitomo Pharma America, Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: CNS | ||||||
| 06/01/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Neurology | ||||||
| 05/30/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GAMMAGARD (Biological) | Food and Beverage | In-kind items and services | $28.34 | General |
| Category: IMMUNOLOGY | ||||||
| 05/18/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $41.75 | General |
| Category: NEUROLOGY | ||||||
| 05/17/2023 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $19.14 | General |
| Category: NEUROLOGY | ||||||
| 05/10/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: NEUROSCIENCE | ||||||
| 04/27/2023 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Immunology | ||||||
| 04/21/2023 | Neurocrine Biosciences, Inc. | Ongentys (Drug), INGREZZA | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Neuropsychiatry | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 395 | 444 | $105,290 | $30,086 |
| 2022 | 5 | 346 | 412 | $87,320 | $26,853 |
| 2021 | 6 | 373 | 447 | $103,946 | $33,001 |
| 2020 | 7 | 334 | 377 | $68,406 | $19,572 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 114 | 147 | $32,928 | $10,014 | 30.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 51 | 57 | $17,214 | $5,944 | 34.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 44 | 44 | $18,832 | $5,451 | 28.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 48 | 49 | $10,976 | $2,908 | 26.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 64 | 69 | $10,350 | $2,541 | 24.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 49 | 53 | $7,950 | $2,238 | 28.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 13 | 13 | $2,912 | $502.95 | 17.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $4,128 | $488.09 | 11.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 102 | 128 | $28,672 | $9,412 | 32.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 103 | 127 | $19,050 | $5,758 | 30.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 33 | 39 | $11,778 | $4,399 | 37.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 25 | 25 | $10,700 | $3,213 | 30.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 60 | 68 | $10,200 | $2,606 | 25.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $3,784 | $759.49 | 20.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 12 | 14 | $3,136 | $706.25 | 22.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 103 | 151 | $33,824 | $10,967 | 32.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 52 | 60 | $18,120 | $6,686 | 36.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 103 | 117 | $17,550 | $6,057 | 34.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 43 | 43 | $18,404 | $5,144 | 28.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 40 | 44 | $6,600 | $1,869 | 28.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 19 | 19 | $6,536 | $1,738 | 26.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 13 | 13 | $2,912 | $540.46 | 18.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 68 | 85 | $19,040 | $5,441 | 28.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 101 | 120 | $18,000 | $5,137 | 28.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 47 | 47 | $16,168 | $4,278 | 26.5% |
About Heather Hitesman, ARNP
Heather Hitesman, ARNP is a Acute Care healthcare provider based in Davenport, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/11/2016. The National Provider Identifier (NPI) number assigned to this provider is 1992259642.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Heather Hitesman, ARNP has received a total of $1,572 in payments from pharmaceutical and medical device companies, with $388.88 received in 2024. These payments were reported across 81 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($1,560).
As a Medicare-enrolled provider, Hitesman has provided services to 1,448 Medicare beneficiaries, totaling 1,680 services with total Medicare billing of $109,512. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Acute Care
- Location Davenport, IA
- Active Since 08/11/2016
- Last Updated 04/15/2021
- Taxonomy Code 363LA2100X
- Entity Type Individual
- NPI Number 1992259642
Products in Payments
- Sunosi (Drug) $213.25
- QULIPTA (Drug) $131.35
- KESIMPTA (Drug) $110.99
- UBRELVY (Drug) $102.91
- TYSABRI (Biological) $77.64
- RYTARY (Drug) $68.20
- INSPIRE (Device) $67.71
- VALTOCO (Drug) $64.17
- Leqembi (Drug) $43.13
- INGREZZA (Drug) $39.83
- Ongentys (Drug) $37.90
- VYEPTI (Biological) $35.90
- NURTEC ODT (Drug) $34.56
- Aimovig (Biological) $34.12
- Trudhesa (Drug) $33.58
- QUVIVIQ (Drug) $33.15
- APOKYN (Drug) $32.47
- VUMERITY (Drug) $29.55
- GAMMAGARD (Biological) $28.34
- Nourianz (Drug) $27.67
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Acute Care Doctors in Davenport
Ms. Jessica Witter, Arnp, ARNP
Acute Care — Payments: $4,981
Shawna Duske, Acnp, ACNP
Acute Care — Payments: $2,062
Lori Schwarm, Arnp, ARNP
Acute Care — Payments: $905.15
Gina Zelle, Dnp, Agacnp-Bc, DNP, AGACNP-BC
Acute Care — Payments: $901.58
Dr. Cheryl Ehrler, Dnp, Arnp, Agacnp-Bc, DNP, ARNP, AGACNP-BC
Acute Care — Payments: $855.05
Cynthia Burkholder, Arnp, ARNP
Acute Care — Payments: $728.87